Trial · NCT04432831
Adverse events987
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 987
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Cataract | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 65 | 491 | 65 |
| other | Cataract | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 60 | 500 | 60 |
| other | Cataract | Eye disorders | Faricimab PTI (Prior Aflibercept Q8W) | 63 | 473 | 63 |
| other | Diabetic retinal oedema | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 22 | 491 | 22 |
| other | Diabetic retinal oedema | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 27 | 500 | 31 |
| other | Diabetic retinal oedema | Eye disorders | Faricimab PTI (Prior Aflibercept Q8W) | 24 | 473 | 27 |
| other | Posterior capsule opacification | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 16 | 491 | 17 |
| other | Posterior capsule opacification | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 17 | 500 | 17 |
| other | Posterior capsule opacification | Eye disorders | Faricimab PTI (Prior Aflibercept Q8W) | 14 | 473 | 14 |
| other | COVID-19 | Infections and infestations | Faricimab PTI (Prior Faricimab Q8W) | 63 | 491 | 70 |
| other | COVID-19 | Infections and infestations | Faricimab PTI (Prior Faricimab PTI) | 49 | 500 | 50 |
| other | COVID-19 | Infections and infestations | Faricimab PTI (Prior Aflibercept Q8W) | 46 | 473 | 49 |
| other | Conjunctival haemorrhage | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 16 | 491 | 17 |
| other | Conjunctival haemorrhage | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 9 | 500 | 9 |
| other | Conjunctival haemorrhage | Eye disorders | Faricimab PTI (Prior Aflibercept Q8W) | 5 | 473 | 5 |
| other | Diabetic retinopathy | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 17 | 491 | 17 |
| other | Diabetic retinopathy | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 8 | 500 | 8 |
| other | Diabetic retinopathy | Eye disorders | Faricimab PTI (Prior Aflibercept Q8W) | 12 | 473 | 12 |
| other | Vitreous detachment | Eye disorders | Faricimab PTI (Prior Faricimab Q8W) | 16 | 491 | 16 |
| other | Vitreous detachment | Eye disorders | Faricimab PTI (Prior Faricimab PTI) | 12 | 500 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04432831/events